Clinical trials for Russian COVID-19 vaccine candidate Sputnik V have commenced in India and are set to involve 1,600 volunteers at nine sites across the country. Dr. Reddy’s Laboratories and the Russian Direct Investment Fund, which partnered the drugmaker for the trials and distribution of the first 100 million doses in India, on Tuesday said the adaptive phase 2/3 trials …
Kanpur: The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted, according to a report. The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy's Laboratories got …
Russia’s Sputnik V vaccine for coronavirus is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted. The Drug Control General of India had granted approval to Russian Direct Investment Fund and Dr Reddy's Laboratories Ltd to conduct late-stage clinical trials of the Russian …
